282 related articles for article (PubMed ID: 21672052)
1. Dipeptidyl peptidase IV (DPP4) deficiency increases Th1-driven allergic contact dermatitis.
Tasic T; Bäumer W; Schmiedl A; Schwichtenhövel F; Pabst R; Raap U; von Hörsten S; Stephan M
Clin Exp Allergy; 2011 Aug; 41(8):1098-107. PubMed ID: 21672052
[TBL] [Abstract][Full Text] [Related]
2. Maternal allergic contact dermatitis causes increased asthma risk in offspring.
Lim RH; Arredouani MS; Fedulov A; Kobzik L; Hubeau C
Respir Res; 2007 Jul; 8(1):56. PubMed ID: 17662138
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase IV (DPP4)-deficiency attenuates diet-induced obesity in rats: possible implications for the hypothalamic neuropeptidergic system.
Stephan M; Radicke A; Leutloff S; Schmiedl A; Pabst R; von Hörsten S; Dettmer S; Lotz J; Nave H
Behav Brain Res; 2011 Jan; 216(2):712-8. PubMed ID: 20887754
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
Neis MM; Peters B; Dreuw A; Wenzel J; Bieber T; Mauch C; Krieg T; Stanzel S; Heinrich PC; Merk HF; Bosio A; Baron JM; Hermanns HM
J Allergy Clin Immunol; 2006 Oct; 118(4):930-7. PubMed ID: 17030248
[TBL] [Abstract][Full Text] [Related]
5. CD26 (dipeptidyl-peptidase IV)-dependent recruitment of T cells in a rat asthma model.
Kruschinski C; Skripuletz T; Bedoui S; Tschernig T; Pabst R; Nassenstein C; Braun A; von Hörsten S
Clin Exp Immunol; 2005 Jan; 139(1):17-24. PubMed ID: 15606609
[TBL] [Abstract][Full Text] [Related]
6. Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis.
Newell L; Polak ME; Perera J; Owen C; Boyd P; Pickard C; Howarth PH; Healy E; Holloway JW; Friedmann PS; Ardern-Jones MR
J Invest Dermatol; 2013 Oct; 133(10):2372-2380. PubMed ID: 23528819
[TBL] [Abstract][Full Text] [Related]
7. Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats.
Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K; Nakahori Y
J Endocrinol; 2009 Jan; 200(1):53-61. PubMed ID: 18931022
[TBL] [Abstract][Full Text] [Related]
8. Allergic manifestations of skin diseases--atopic dermatitis.
Breuer K; Werfel T; Kapp A
Chem Immunol Allergy; 2006; 91():76-86. PubMed ID: 16354950
[TBL] [Abstract][Full Text] [Related]
9. Gene expression in canine atopic dermatitis and correlation with clinical severity scores.
Wood SH; Clements DN; Ollier WE; Nuttall T; McEwan NA; Carter SD
J Dermatol Sci; 2009 Jul; 55(1):27-33. PubMed ID: 19394200
[TBL] [Abstract][Full Text] [Related]
10. Contact allergic response to dinitrochlorobenzene (DNCB) in rats: insight from sensitization phase.
Popov A; Mirkov I; Miljković D; Belij S; Zolotarevski L; Kataranovski D; Kataranovski M
Immunobiology; 2011 Jul; 216(7):763-70. PubMed ID: 21281978
[TBL] [Abstract][Full Text] [Related]
11. Role of dipeptidyl peptidase IV (DPP4) in the development of dyslipidemia: DPP4 contributes to the steroid metabolism pathway.
Sato Y; Koshioka S; Kirino Y; Kamimoto T; Kawazoe K; Abe S; Minakuchi K; Nakahori Y
Life Sci; 2011 Jan; 88(1-2):43-9. PubMed ID: 21047519
[TBL] [Abstract][Full Text] [Related]
12. Differential severity of LPS-induced lung injury in CD26/DPP4 positive and deficient F344 rats.
Zientara A; Stephan M; von Hörsten S; Schmiedl A
Histol Histopathol; 2019 Oct; 34(10):1151-1171. PubMed ID: 30977110
[TBL] [Abstract][Full Text] [Related]
13. Immunostimulatory sequence CpG elicits Th1-type immune responses in inflammatory skin lesions in an atopic dermatitis murine model.
Wang G; Fyhrquist-Vanni N; Wolff H; Dieu-Nosjean MC; Kemeny L; Homey B; Lauerma AI; Alenius H
Int Arch Allergy Immunol; 2008; 147(1):41-51. PubMed ID: 18446052
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseases.
von Bonin A; Rausch A; Mengel A; Hitchcock M; Krüger M; von Ahsen O; Merz C; Röse L; Stock C; Martin SF; Leder G; Döcke WD; Asadullah K; Zügel U
Exp Dermatol; 2011 Jan; 20(1):41-7. PubMed ID: 21158938
[TBL] [Abstract][Full Text] [Related]
15. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis.
Trautmann A; Akdis M; Schmid-Grendelmeier P; Disch R; Bröcker EB; Blaser K; Akdis CA
J Allergy Clin Immunol; 2001 Nov; 108(5):839-46. PubMed ID: 11692113
[TBL] [Abstract][Full Text] [Related]
16. Differential OVA-induced pulmonary inflammation and unspecific reaction in Dark Agouti (DA) rats contingent on CD26/DPPIV deficiency.
Tasic T; Stephan M; von Hörsten S; Pabst R; Schmiedl A
Immunobiology; 2014 Nov; 219(11):888-900. PubMed ID: 25108564
[TBL] [Abstract][Full Text] [Related]
17. Development and resolution of colitis in mice with target deletion of dipeptidyl peptidase IV.
Detel D; Pugel EP; Pucar LB; Buljevic S; Varljen J
Exp Physiol; 2012 Apr; 97(4):486-96. PubMed ID: 22125312
[TBL] [Abstract][Full Text] [Related]
18. Impaired responses of peripheral blood mononuclear cells to nickel in patients with nickel-allergic contact dermatitis and concomitant atopic dermatitis.
Buchvald D; Lundeberg L
Br J Dermatol; 2004 Mar; 150(3):484-92. PubMed ID: 15030331
[TBL] [Abstract][Full Text] [Related]
19. TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis. Effects of cilomilast and diflorasone diacetate on T-cell-attracting chemokines.
Bäumer W; Seegers U; Braun M; Tschernig T; Kietzmann M
Br J Dermatol; 2004 Oct; 151(4):823-30. PubMed ID: 15491423
[TBL] [Abstract][Full Text] [Related]
20. Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice.
Baticic L; Detel D; Kucic N; Buljevic S; Pugel EP; Varljen J
J Cell Biochem; 2011 Nov; 112(11):3322-33. PubMed ID: 21751235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
